CRISPR-Based Gene Dependency Screens reveal Mechanism of BRAF Inhibitor Resistance in Anaplastic Thyroid Cancer. The gene discussed is BRAF; the disease is thyroid gland undifferentiated (anaplastic) carcinoma.